Syftet med den här studien var att undersöka om en möjlig framgångsrik implementering avett biometriskt system kommer att leda till ett ökat anat resenärer som använder bussbolagetstjänster, utifrån passagerarperspektiv. I studien undersöker jag vilken typ av biometriskt system som är mest troligt att bliaccepterat av busspassagerarna och vad det kan bero på, hur bussbolaget kan marknadsförabiometriska system till passagerarna för att skapa mer värde för passagerarna samtundersöker hur kunderna anser att bussbolaget kan agera för att busspassagerarna skaacceptera ett biometriskt system. Studien baseras på en enkätundersökning baserad på mina undersökningsfrågor och minanalysmodell som användes för att analysera resultatet. Enkätundersökningen är uppbyggd av16 frågor med svarsalternativ som består av en graderad inställning. Resultatet presenteras i form av stycken utifrån analysmodellens uppbyggnad därresultatet från enkätundersökningen ställs mot teorin. Studien resulterar i tre stycken slutsatser, den första slutsatsen är att Automatic PassengerCounting är det biometriska system som har högst trolighet att bli accepterat avbusspassagerarna och det beror på att busspassagerarna högt värdesätter att bussbolagensbussar inte är fulla och att det inte är trängsel på bussarna samt att bussbolagen sätter in extrainsatta bussar om det skulle krävas. Den andra slutsatsen är att det bästa sättet att marknadsföra biometri mot passagerarna ärvia appen då flest busspassagerare tycker att appen är det bästa stället att se marknadsföring. Den tredje och sista slutsatsen är att bussbolagen behöver bevisa för passagerarna att detar säkerheten och lagringen av passagerarnas uppgifter på allvar och hur de planerar attadressera integritetsoron

京都大学 / 0048 / 新制・論文博士 / 博士(医学) / 乙第13139号 / 論医博第2139号 / 新制||医||1026(附属図書館) / 京都大学大学院医学研究科医学専攻 / (主査)教授 松田 道行, 教授 中川 一路, 教授 原田 浩 / 学位規則第4条第2項該当 / Doctor of Medical Science / Kyoto University / DFAM

No description available.

台灣地區居民近年的死亡率下降速度加快，使得我國國民的平均壽命在公元2000年已超過美國，成為長壽的國家之一。其中我國國民死亡率的下降幅度因年齡而不同，且各個年代、世代也不相同，與APC（Age-Period-Cohort）模型採年齡、年代與世代三個因子分析死亡率頗為一致，因此本文計畫以APC模型研究台灣的死亡率。然而，由於「年代＝年齡＋世代」之線性相關，參數估計值有甄別問題（Identification Problem），使得參數估計值不唯一。 文獻中有不同方法解決APC模型的參數估計問題，近年又有Fu（2000）提出之本質估計量（Intrinsic Estimator），可直接解決參數估計及其變異數。因此本文首先以電腦模擬驗證本質估計量，以及過去其他估計方法，檢測這些方法是否可得出理論的結果。本文的第二部分則以西元1961至2005年的資料探討APC模型的實用性，分析APC與Lee-Carter模型的優劣；研究發現APC模型用於估計死亡率時，整體而言雖不如Lee-Carter模型，但可彌補Lee-Carter模型在高年齡有較大誤差的不足，唯在年輕族群則仍有改善空間，未來或可考慮APC與Lee-Carter模型的結合。 / The mortality rates in Taiwan area have been experiencing dramatic decreases in recent years. The life expectancy has surpassed that in the United States in 2000 and Taiwan has become one of the longevity countries. Besides, the falling of mortality rates varies in different age, period, and cohort groups, which corresponds to the APC (Age-Period-Cohort) model. Therefore, the goal of this paper is to study the mortality rates in Taiwan area with APC model. However, due to the linear dependency of age, period and cohort (Period = Age + Cohort), there is the identification problem, that is, the parameter estimates are not unique. A number of solutions to the identification problem in APC model have been provided in the literature. Fu (2000) introduce a new estimator, the Intrinsic Estimator (IE), which can solve parameter estimates and variance directly. In the first part of this research, computer simulation is conducted to examine the IE, compared with other methodologies. In the second part of this research, data from 1961 to 2005 are used for verifying the validity of APC model in fitting mortality rates, and we analyze the strengths and weaknesses between the APC and Lee-Carter model. The results from our study indicate that the APC model in estimating mortality rates does not show as well as the Lee-Carter model as a whole. However, the APC model performs better than the Lee-Carter model for the elderly mortality rates, but is still needed to be improved in young groups. In the future, it can be considered to combine the APC and Lee-Carter model.

La régulation post-transcriptionnelle joue un rôle de premier plan dans le contrôle fin de l’expression génique en permettant une modulation de la synthèse de protéines dans le temps et l’espace, en fonction des besoins de la cellule. Ainsi, des protéines reconnaissant des éléments d’ARN présents sur des transcrits peuvent influencer toutes les étapes de leur existence, soit leur épissage, leur export nucléaire, leur localisation subcellulaire, leur traduction et leur dégradation. Staufen1 (Stau1) est un membre de la famille des protéines liant l’ARN double-brin qui contribue à la régulation post-transcriptionnelle par son implication dans des mécanismes qui vont promouvoir l’épissage alternatif, le transport, la dé-répression de la traduction et l’induction de la dégradation d’ARN messagers (ARNm) spécifiques. L’identité des cibles potentielles de Stau1 est maintenant connue puisqu’une étude à l’échelle du génome a montré que la protéine s’associe à près de 7% du transcriptome des cellules HEK293T. Ces ARNm se classent dans un large éventail de catégories fonctionnelles, mais il est tout de même intéressant de noter qu’une grande proportion d’entre eux code pour des protéines reliées au métabolisme cellulaire et à la régulation de processus cellulaires. En considérant toutes ces informations, nous avons émis l’hypothèse que les différentes activités de Stau1 puissent être modulées afin de contrôler adéquatement l’expression des transcrits liés par la protéine. Dans la mesure où certains ARNm faisant partie des complexes définis par la présence de Stau1 codent pour des régulateurs clés de la prolifération cellulaire, nous avons voulu examiner si l’expression de la protéine varie au cours du cycle de division cellulaire. Nous avons montré que l’abondance de Stau1 est maximale en début de mitose et qu’elle diminue ensuite lorsque les cellules complètent la division cellulaire. Nous avons ensuite découvert que cette baisse d’expression de Stau1 en sortie de mitose dépend du complexe promoteur d’anaphase/cyclosome (APC/C). En soutien à l’idée que Stau1 soit une cible de cette ubiquitine ligase de type E3, nous avons de plus démontré que Stau1 est ubiquitiné et dégradé par le protéasome. Ce contrôle des niveaux de Stau1 semble important puisque la surexpression de la protéine retarde la sortie de mitose et entraîne une diminution importante de la prolifération cellulaire. Par ailleurs, nous avons supposé que les différentes fonctions de Stau1 puissent également être sujettes à une régulation. Compte tenu que les activités de nombreuses protéines liant l’ARN peuvent être contrôlées par des modifications post-traductionnelles telles que la phosphorylation, nous avons voulu tester la possibilité que Stau1 soit phosphorylé. L’immunopurification de Stau1 et son analyse par spectrométrie de masse nous a permis d’identifier trois phosphosites dans la protéine. L’évaluation du rôle de ces événements de phosphorylation à l’aide de mutants phoshomimétiques ou non-phoshorylables a révélé que la modification de Stau1 pourrait compromettre son association à la protéine UPF1. Comme cette interaction est nécessaire pour déstabiliser les transcrits liés par Stau1, nos résultats suggèrent fortement que la fonction de Stau1 dans la dégradation d’ARNm est régulée négativement par sa phosphorylation. Toutes ces données mettent en lumière l’importance des modifications post-traductionnelles telles que l’ubiquitination et la phosphorylation dans la modulation de l’expression et des fonctions de Stau 1. Somme toute, il est vraisemblable que ces mécanismes de contrôle puissent avoir un impact significatif sur le destin des ARNm liés par Stau1, particulièrement dans un contexte de progression dans le cycle cellulaire. / Post-transcriptional regulation plays a major role in the fine tuning of gene expression by allowing a modulation of protein synthesis in space and time, according to cellular requirements. For instance, proteins recognizing RNA elements on transcripts can influence all the steps of their existence, such as their splicing, nuclear export, subcellular localization, translation and degradation. Staufen1 (Stau1) is a member of the double-stranded RNA-binding protein family that contributes to the post-transcriptional regulation of gene expression by its involvement in mechanisms that promote alternative splicing, transport, de-repression of translation and decay of specific messenger RNAs (mRNAs). The identity of potential Stau1 targets is now known as genome-wide analyses have shown that the protein is associated with about 7% of the HEK293T cell transcriptome. Although these mRNAs are classified in a broad range of functional categories, a large proportion of them code for proteins related to cellular metabolism and regulation of cellular processes. Considering all this information, we hypothesized that the different activities of Stau1 may be modulated in order to control appropriately the expression of Stau1-bound mRNAs. Since some of the mRNAs that are part of Stau1-containing complexes encode key regulators of cell proliferation, we wanted to examine whether Stau1 expression fluctuates during the cell division cycle. We showed that Stau1 abundance peaks at the onset of mitosis and then decreases as cells complete division. We then found that Stau1 down-regulation in mitosis exit is mediated by the anaphase promoting complex/cyclosome (APC/C). To support the idea that Stau1 is a target of this E3-ubiquitin ligase, we further demonstrated that Stau1 is ubiquitinated and degraded by the proteasome. The importance of controlling Stau1 levels during the cell cycle is underscored by the observation that its overexpression delays mitotic exit and impairs cell proliferation. Furthermore, we speculated that Stau1 different functions may also be regulated. In the view that the activities of numerous RNA-binding proteins can be controlled by post-translational modifications such as phosphorylation, we tested the possibility that Stau1 is phosphorylated. Mass spectrometry analysis of immunopurified Stau1 allowed the identification of three phosphosites in this protein. Assessment of the role of these phosphorylation events using phosphomimetic or non-phosphorylatable mutants revealed that Stau1 phosphorylation may compromise its association with Upf1. Because this interaction is necessary to elicit the destabilisation of Stau1-bound RNAs, our results strongly suggest that Stau1 function in mRNA decay is negatively regulated by its phosphorylation. Collectively, these data highlight the importance of post-translational modifications such as ubiquitination and phosphorylation in the modulation of Stau1 expression and functions. Overall, the mechanisms that control Stau1 are likely to have a significant impact on the fate of Stau1-bound mRNAs, especially in the context of cell cycle progression.

O câncer de mama é a neoplasia responsável pelo maior número de mortes em mulheres no Brasil, portanto, é importante encontrar novos marcadores específicos e de diagnóstico precoce, utilizando procedimentos simples e rápidos. A via de sinalização Wnt regula importantes funções celulares como proliferação, sobrevida e adesão. Esta via está associada com os processos de iniciação e progressão em muitos tipos tumorais, como câncer de cólon familiar, melanoma e pulmão; sendo que mutações em β-Catenina (CTNNb1) explicam só 30% dos casos de sinalização aberrante encontrada no câncer de mama, indicando que existem outros componentes e/ou reguladores da via que possam estar envolvidos. O objetivo deste trabalho foi avaliar as variantes genéticas e epigenéticas nos genes do complexo de degradação de β-Catenina num grupo de pacientes com câncer de mama e num grupo controle; e determinar os perfis de transcrição dos componentes da via de sinalização Wnt e da molécula de expressão exclusiva do epitélio mamário, a Mamaglobina Humana (MGA), assim como associar estes resultados com as características clínicas, histológicas e patológicas do tumor. Para atingir este objetivo foram coletadas amostras de sangue periférico de 102 mulheres com câncer de mama e 102 mulheres sadias como grupo controle. A avaliação das variantes rs465899 do gene APC, rs2240308 e rs151279728 do gene AXIN2, rs5030625 do gene CDH1 e rs334558 do gene GSK3, foi realizada por meio de PCR-RFLPs e sequenciamento, a análise dos perfis de metilação dos promotores pela MS-PCR. A RT-qPCR foi usada para determinar os níveis de expressão dos componentes da via e a MGA. As variantes rs2240308 e rs151279728 do gene AXIN2 mostraram uma forte associação com o risco de desenvolver o câncer de mama. Um aumento significativo foi observado no nível de expressão de AXIN2 no grupo de mulheres com câncer de mama. Análises adicionais mostraram perfis de expressão diferencial dos genes APC, AXIN2, CTNNB1, GSK3 e CSNK1A1 associado ao status dos receptores hormonais e histogênese tumoral. MGA foi identificado exclusivamente em 38% dos pacientes com câncer de mama e foi associada com a progressão da doença. Este é o primeiro estudo que relaciona uma variante do gene AXIN2 com o câncer de mama na população brasileira. As variantes avaliadas do gene AXIN2 são marcadores promissores de susceptibilidade ao câncer de mama na população estudada, sendo importante, a avaliação desta variante genética na população e determinar o seu real efeito no processo de iniciação e/ou progressão do câncer de mama. / Background: Wnt/β-catenin signaling pathway is an important regulator of cellular functions such as proliferation, survival and cell adhesion. This pathway is associated with tumor initiation and progression; -catenin (CTNNB1) mutations explains only 30% of aberrant signaling found in breast cancer, indicating that other components and/or regulating of the Wnt/β-catenin pathway may be involved. Objective: The objective of the study was to evaluate the APC rs465899, AXIN2 rs2240308 and rs151279728, CDH1 rs5030625 and GSK3 rs334558 polymorphisms, APC, AXIN2, CDH1 and GSK3 promoter methylation status and expression profile of -Catenin destruction complex genes and MGA in peripheral blood of breast cancer patients. Methods: We collected peripheral blood samples from 102 breast cancer and 102 healthy subjects. The identification of the mutation was performed using PCR-RFLPs and DNA sequencing. MSP and HRM-MS was used to measure promoter methylation and RT-qPCR to determine expression profile. Results: We found significant association of AXIN2 rs2240308 polymorphism with breast cancer. Increased risk was observed even after stratification based on clinicpathological characteristics. AXIN2 rs151279728 polymorphism was found only in 9 breast cancer patients, but none in control group subject. APC and CDH1 polymorphisms were not associated with breast cancer. GSK3 polymorphism was weak associated with breast cancer and heterozygous status was associated with breast cancer protection after group stratification. APC and CDH1 promoter methylation in breast cancer patients was found. Significant increase was observed in AXIN2, CTNNB1 and GSK3 level expression in breast cancer patients. APC was down-regulated in breast cancer patients. Further analyses, showed APC, AXIN2, CTNNB1, GSK3 and CSKN1A1 gene expression associated to receptor status and histological type. MGA was found only in breast cancer patients and was associated with cancer progression. Conclusion: The present study reports, for the first time, that AXIN2 genetic defect and -catenin destruction complex expression disturbance may be found in breast cancer patients, providing additional support to the role of Wnt/-catenin pathway dysfunction in breast cancer tumorigenesis. However, the functional consequence of this genetic alteration remains to be determined. In another hand MGA was determined like a good biomarker for diagnosis and prognosis outcome.

The immune system is essential for keeping the integrity of multicellular organisms. We were able to make a step forward in studying the complex immune reactions in mammals in vivo and/ or in situ using the major histocompatibility complex (MHC) class II/ enhanced green fluorescent protein (EGFP) knock-in mouse model. Due to the EGFP visualization of MHC II expressing cells we were able to observe antigen presenting cells, which are essential for the onset of immune responses, in their natural environment. Thus, we report some original features of the immune system. We have identified MHC II+ cell clusters with unknown, probably unique function, in the intestine. We have also described MHC II+ cell migration to the lactating mammary gland and tested few hypotheses about the role of this phenomenon for the development of the mammary gland, milk secretion or infant immune system establishment. Lastly, we observed residential macrophages in the cornea. The presence of APCs in the cornea is a very contradictory issue due to the fact that cornea is an immunologically privileged tissue and therefore harbors special immune features. key words: antigen presenting cells (APC), major histocompatibility complex class II (MHC II), enhanced green fluorescent protein (EGFP), immune system, knock-in mouse model

O câncer de mama é a neoplasia responsável pelo maior número de mortes em mulheres no Brasil, portanto, é importante encontrar novos marcadores específicos e de diagnóstico precoce, utilizando procedimentos simples e rápidos. A via de sinalização Wnt regula importantes funções celulares como proliferação, sobrevida e adesão. Esta via está associada com os processos de iniciação e progressão em muitos tipos tumorais, como câncer de cólon familiar, melanoma e pulmão; sendo que mutações em β-Catenina (CTNNb1) explicam só 30% dos casos de sinalização aberrante encontrada no câncer de mama, indicando que existem outros componentes e/ou reguladores da via que possam estar envolvidos. O objetivo deste trabalho foi avaliar as variantes genéticas e epigenéticas nos genes do complexo de degradação de β-Catenina num grupo de pacientes com câncer de mama e num grupo controle; e determinar os perfis de transcrição dos componentes da via de sinalização Wnt e da molécula de expressão exclusiva do epitélio mamário, a Mamaglobina Humana (MGA), assim como associar estes resultados com as características clínicas, histológicas e patológicas do tumor. Para atingir este objetivo foram coletadas amostras de sangue periférico de 102 mulheres com câncer de mama e 102 mulheres sadias como grupo controle. A avaliação das variantes rs465899 do gene APC, rs2240308 e rs151279728 do gene AXIN2, rs5030625 do gene CDH1 e rs334558 do gene GSK3, foi realizada por meio de PCR-RFLPs e sequenciamento, a análise dos perfis de metilação dos promotores pela MS-PCR. A RT-qPCR foi usada para determinar os níveis de expressão dos componentes da via e a MGA. As variantes rs2240308 e rs151279728 do gene AXIN2 mostraram uma forte associação com o risco de desenvolver o câncer de mama. Um aumento significativo foi observado no nível de expressão de AXIN2 no grupo de mulheres com câncer de mama. Análises adicionais mostraram perfis de expressão diferencial dos genes APC, AXIN2, CTNNB1, GSK3 e CSNK1A1 associado ao status dos receptores hormonais e histogênese tumoral. MGA foi identificado exclusivamente em 38% dos pacientes com câncer de mama e foi associada com a progressão da doença. Este é o primeiro estudo que relaciona uma variante do gene AXIN2 com o câncer de mama na população brasileira. As variantes avaliadas do gene AXIN2 são marcadores promissores de susceptibilidade ao câncer de mama na população estudada, sendo importante, a avaliação desta variante genética na população e determinar o seu real efeito no processo de iniciação e/ou progressão do câncer de mama. / Background: Wnt/β-catenin signaling pathway is an important regulator of cellular functions such as proliferation, survival and cell adhesion. This pathway is associated with tumor initiation and progression; -catenin (CTNNB1) mutations explains only 30% of aberrant signaling found in breast cancer, indicating that other components and/or regulating of the Wnt/β-catenin pathway may be involved. Objective: The objective of the study was to evaluate the APC rs465899, AXIN2 rs2240308 and rs151279728, CDH1 rs5030625 and GSK3 rs334558 polymorphisms, APC, AXIN2, CDH1 and GSK3 promoter methylation status and expression profile of -Catenin destruction complex genes and MGA in peripheral blood of breast cancer patients. Methods: We collected peripheral blood samples from 102 breast cancer and 102 healthy subjects. The identification of the mutation was performed using PCR-RFLPs and DNA sequencing. MSP and HRM-MS was used to measure promoter methylation and RT-qPCR to determine expression profile. Results: We found significant association of AXIN2 rs2240308 polymorphism with breast cancer. Increased risk was observed even after stratification based on clinicpathological characteristics. AXIN2 rs151279728 polymorphism was found only in 9 breast cancer patients, but none in control group subject. APC and CDH1 polymorphisms were not associated with breast cancer. GSK3 polymorphism was weak associated with breast cancer and heterozygous status was associated with breast cancer protection after group stratification. APC and CDH1 promoter methylation in breast cancer patients was found. Significant increase was observed in AXIN2, CTNNB1 and GSK3 level expression in breast cancer patients. APC was down-regulated in breast cancer patients. Further analyses, showed APC, AXIN2, CTNNB1, GSK3 and CSKN1A1 gene expression associated to receptor status and histological type. MGA was found only in breast cancer patients and was associated with cancer progression. Conclusion: The present study reports, for the first time, that AXIN2 genetic defect and -catenin destruction complex expression disturbance may be found in breast cancer patients, providing additional support to the role of Wnt/-catenin pathway dysfunction in breast cancer tumorigenesis. However, the functional consequence of this genetic alteration remains to be determined. In another hand MGA was determined like a good biomarker for diagnosis and prognosis outcome.

The purpose of this thesis is to develop a model to enhance the effectiveness of machining centers with multi-pallet automatic pallet changers (APCs). From critical literature review no existing theories within this field were found. The multi-pallet APC allows multi-setups and a more flexible sequencing of jobs. The model together with the developed heuristic scheduling algorithm with the objective to minimize the total weighted tardiness can be used to plan in n jobs on m pallets in a shop-floor. The right maintenance policy ensures a high availability, which together with the program guarantees a high level of utilization of the machinery. Consequently the effectiveness will be enhanced. A case study approach was used to test the model at Växjöfabriken in Sweden, which treats cast material. The results of this case study are a more effective utilization of the machines with decreased tardiness costs, increased customers’ satisfaction and goodwill of the company. The contribution of this thesis is a model with a flexible, adjustable and expandable heuristic scheduling algorithm, which can be applied in all manufacturing companies using machining centers with multi-pallet APCs. / Syftet med denna uppsats är att utveckla en modell för att förbättra effektiviteten av maskincentra med automatiska palletväxlare (APCs) för multi-palleter. När en kritisk litteratursökning genomfördes hittades inga relevanta teorier inom det aktuella området. Multi-pallet APC tillåter att många jobb kan förberedas samtidigt och gör planeringen av jobben mer flexibel. Modellen, tillsammans med den utvecklade heuristiska planeringsalgoritmen med målet att minimera den totala viktade förseningen, kan användas för att planera in n jobb med m palleter på ett verkstadsgolv. Rätt underhålls policy försäkrar en hög tillgänglighet vilket tillsammans med programmet garanterar en hög utnyttjandenivå av maskinerna. Som följd kommer effektiviteten att höjas. En fallstudie utfördes på Växjöfabriken i Sverige för att utvärdera modellen, på företaget efterbehandlas gjutgods. Resultatet från denna fallstudie blev ett effektivare utnyttjande av maskinerna, med minskade förseningskostnader, ökad kundtillfredställelse och goodwill för företaget. Denna uppsats bidrar med en modell och en flexibel, anpassningsbar och utvecklingsbar heuristisk planeringsalgoritm, vilken kan användas i alla industriföretag som använder maskincentra med multi-pallet APCs.

Meiosis is a specialized cell cycle, which generates haploid gametes from diploid parental cells. During meiosis one round of cohesion establishment during premeiotic DNA replication mediates two rounds of chromosome segregation. During meiosis I homologous chromosomes separate, whereas sister chromatids segregate during the second meiotic division without an intervening round of DNA replication. Both rounds of chromosome segregation are triggered by an ubiquitin ligase called the Anaphase-Promoting Complex or Cyclosome (APC/C). APC/C-dependent destruction of securin/Pds1 is required to activate separase, a thiol protease that mediates chromosome segregation by cleavage of the cohesin complex. The first meiotic division is preceded by an extended prophase I, during which maternal and paternal chromatids undergo recombination. The persistence of cohesion during premeiotic S- and prophase I is essential for recombination and both meiotic nuclear divisions. In order to prevent premature loss of cohesion, the APC/C has to be inactivated during early meiosis. How the APC/C is kept inactive during premeiotic S- and prophase I was unknown. This question has been addressed by studying the APC/C subunit Mnd2 from the budding yeast Saccharomyces cerevisiae. This work demonstrates that Mnd2 is required for the persistence of cohesion during premeiotic S- and prophase I. Mnd2 prevents premature activation of the APC/C by the meiosis-specific substrate recognition factor Ama1. In cells lacking Mnd2, the APC/C-Ama1 enzyme triggers premature ubiquitin-dependent degradation of Pds1, which leads to premature separation of sister chromatids due to an unrestrained activity of separase. Thus, chromosome segregation during meiosis depends on both inhibition of a meiosis-specific APC/C and timely activation of APC/C- dependent proteolysis. / Die Meiose ist ein spezialisierter Zellzyklus, der zum Ziel hat haploide Gameten aus diploiden Vorläuferzellen zu produzieren. Dafür erfolgen nach der prä-meiotischen DNA Replikation zwei aufeinanderfolgende Kernteilungen. In der ersten meiotischen Teilung erfolgt die Trennung der homologen Chromosomen. In einer zweiten meiotischen Teilung werden dann die Schwesterchromatiden getrennt. Die Trennung der Chromosomen wird durch den Anaphase-Promoting Complex oder Cyclosome (APC/C), einer Ubiquitin Ligase, reguliert. Der APC/C initiiert den Abbau von Securin/Pds1, einem Inhibitor der Thiol-Protease Separase, welche für die Trennung der Chromosomen zum Beginn der Anaphase verantwortlich ist. In einer im Vergleich zur Mitose extrem langen meiotischen Prophase I findet Rekombination zwischen maternalen und paternalen Chromosomen statt. Für diesen Vorgang, sowie für die beiden folgenden meiotischen Teilungen, wird Kohäsion zwischen den Schwesterchromatiden benötigt. Ein frühzeitiger Verlust der Kohäsion führt zur frühzeitigen Trennnung der Schwesterchromatiden, wodurch aneuploide Gameten produziert werden können. Daher muss die Aktivität des APC/C während der meiotischen Prophase I inhibiert werden. Wie der APC/C während der Prophase I inaktiviert wird, war bisher unbekannt. Einsicht in dieses Problem ergab sich aus der Untersuchung der APC/C Untereinheit Mnd2 aus der Bäckerhefe Saccharomyces cerevisiae. Es wird gezeigt, dass Mnd2 für den Verbleib der Kohäsion zwischen den Schwesterchromatiden während der meiotischen S- und Prophase I benötigt wird. Während dieser Phase verhindert Mnd2 die frühzeitige Aktivierung der Meiose-spezifischen Form des APC/C-Ama1. In meiotischen Zellen, die kein Mnd2 besitzen, löst das APC/C-Ama1 Enzym die Ubiquitin-abhängige Zerstörung von Pds1 aus. Dies führt zu einer frühzeitigen Aktivierung von Separase, welches die Trennung der Schwesterchromatiden schon während der meiotischen S- und Prophase I zur Folge hat. Die korrekte Verteilung der Chromosomen hängt daher sowohl von der Inhibierung als auch der Aktivierung des APC/C ab.